CAPONNETTO, SALVATORE
 Distribuzione geografica
Continente #
AS - Asia 524
SA - Sud America 314
NA - Nord America 38
EU - Europa 16
AF - Africa 9
Continente sconosciuto - Info sul continente non disponibili 1
Totale 902
Nazione #
BR - Brasile 252
VN - Vietnam 139
HK - Hong Kong 110
SG - Singapore 105
CN - Cina 86
KR - Corea 47
AR - Argentina 29
MX - Messico 21
EC - Ecuador 15
US - Stati Uniti d'America 12
ID - Indonesia 10
BD - Bangladesh 8
IT - Italia 7
IN - India 6
RU - Federazione Russa 5
CO - Colombia 4
IQ - Iraq 4
PY - Paraguay 4
CL - Cile 3
MA - Marocco 3
PE - Perù 3
VE - Venezuela 3
DO - Repubblica Dominicana 2
EG - Egitto 2
SV - El Salvador 2
TN - Tunisia 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
BG - Bulgaria 1
BH - Bahrain 1
CH - Svizzera 1
DE - Germania 1
DZ - Algeria 1
JO - Giordania 1
KZ - Kazakistan 1
NI - Nicaragua 1
PH - Filippine 1
PS - Palestinian Territory 1
SY - Repubblica araba siriana 1
UA - Ucraina 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZA - Sudafrica 1
Totale 902
Città #
Hong Kong 110
Ho Chi Minh City 63
Seoul 47
Beijing 24
Hanoi 21
São Paulo 17
Singapore 14
Mexico City 13
Da Nang 7
Campinas 5
Guayaquil 5
Haiphong 5
Porto Alegre 5
Quito 5
Belo Horizonte 4
Biên Hòa 4
Juiz de Fora 4
New York 4
Niterói 4
Thái Bình 4
Asunción 3
Barretos 3
Brasília 3
Buenos Aires 3
Bắc Giang 3
Caxias do Sul 3
Dallas 3
Fortaleza 3
Rio de Janeiro 3
Barueri 2
Bauru 2
Bogotá 2
Bình Dương 2
Campina Grande 2
Cesena 2
Concordia 2
Contagem 2
Cruz Alta 2
Cuiabá 2
Curitiba 2
Currais Novos 2
Duque de Caxias 2
Esmeraldas 2
Gravataí 2
Hưng Yên 2
Hải Dương 2
Itabira 2
Lima 2
Londrina 2
Manaus 2
Mauá 2
Milan 2
Osasco 2
Pindamonhangaba 2
Piracicaba 2
Ribeirão Preto 2
Rio Grande 2
Salvador 2
San Juan 2
San Salvador 2
Santiago 2
Santo Domingo 2
Santo Domingo de los Colorados 2
Santos 2
Sorocaba 2
São José do Rio Preto 2
São José dos Campos 2
Uberlândia 2
Agadir 1
Alfenas 1
Altinho 1
Americana 1
Amloh 1
Amman 1
Angra dos Reis 1
Anita Garibaldi 1
Annaba 1
Arapongas 1
Araraquara 1
Armenia 1
Ashburn 1
Astana 1
Baghdad 1
Bagé 1
Barbacena 1
Barinas 1
Barquisimeto 1
Barras 1
Basra 1
Bekasi 1
Belford Roxo 1
Betim 1
Birigui 1
Boa Vista 1
Bom Conselho 1
Bom Jesus de Goiás 1
Bragança 1
Bragança Paulista 1
Bình An 1
Bến Cầu 1
Totale 502
Nome #
RAS Mutation Conversion in Bevacizumab-Treated Metastatic Colorectal Cancer Patients: A Liquid Biopsy Based Study 39
Prognostic value of the BIO-Ra Score in metastatic castration-resistant prostate cancer patients treated with Radium-223 after the European Medicines Agency restricted use: secondary investigations of the multicentric BIO-Ra study 31
Genomic landscape and survival analysis of ctDNA “neo-RAS wild-type” patients with originally RAS mutant metastatic colorectal cancer 29
Impact of sarcopenia and inflammation on patients with advanced non-small cell lung cancer (Ncscl) treated with immune checkpoint inhibitors (icis): a prospective study 28
Circulating methylated dna to monitor the dynamics of ras mutation clearance in plasma from metastatic colorectal cancer patients 27
Adjuvant chemotherapy in resected colon cancer: when, how and how long? 27
Why the Therapeutic Impact of RAS Mutation Clearance in Plasma ctDNA Deserves to Be Further Explored in Metastatic Colorectal Cancer 26
Tumor associated MUC1 carried by microvesicles is cross-processed by dendritic cells generating CD8+ T cell response 26
Identification of Poliovirus Receptor-like 3 Protein as a Prognostic Factor in Triple-Negative Breast Cancer 25
About RAS Mutation Clearance in Plasma ctDNA From RAS-Mutant Colorectal Cancer Patients 24
HE3286, an orally bioavailable synthetic analogue of an active DHEA metabolite suppresses spontaneous autoimmune diabetes in the non-obese diabetic (NOD) mouse 24
Prognostic and predictive role of body mass index (BMI) in metastatic colorectal cancer (mCRC): a pooled analisys of tribe and tribe-2 studies by GONO 24
Genomic landscape and survival analysis of ctDNA “neo-RAS wild-type” patients with originally RAS mutant metastatic colorectal cancer 23
First-, Second-, and Third-Generation Radiolabeled Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Positron Emission Tomography: State of the Art, a Systematic Review 23
Significance of PD-L1 in Metastatic Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors 23
Monitoring PD-L1 positive circulating tumor cells in non-small cell lung cancer patients treated with the PD-1 inhibitor Nivolumab 22
Immunological and clinical impact of cancer stem cells in vulvar cancer: role of CD133/CD24/ABCG2-Expressing Cells 22
Burned-out testicular cancer: really a different history? 22
Lenvatinib Versus Sorafenib in Advanced Hepatic Cell Carcinoma: A Double Center Retrospective Analysis 21
Preliminary efficacy and safety data of nivolumab in never smoker patients with advanced squamous NSCLC: Experience from Italian sites participating in the Expanded Access Programme (EAP) 21
A Comparison Between First-, Second- and Third-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Non-Small-Cell Lung Cancer and Brain Metastases 21
The value of the multidisciplinary team in metastatic renal cell carcinoma: paving the way for precision medicine in toxicities management 20
Response to immunotherapy in KRAS G12C mutated NSCLC: a single-centre retrospective observational study 20
Monitoring PD-L1 positive circulating tumor cells in non-small cell lung cancer patients treated with the PD-1 inhibitor Nivolumab 20
HE3286, an orally bioavailable synthetic analogue of an active DHEA metabolite suppresses spontaneous autoimmune diabetes in the non-obese diabetic (NOD) mouse 20
Merkel cell carcinoma of the retroperitoneum with no identifiable primary site 20
Parkinson's disease is associated with increased serum levels of macrophage migration inhibitory factor 20
Cancer immunotherapy in patients with brain metastases 19
Efficacy and tolerability of selective internal radiotherapy with Yttrium-90 as consolidation treatment after chemotherapy in metastatic colorectal cancer 19
Treatments after progression to first-line FOLFOXIRI and bevacizumab in metastatic colorectal cancer: a pooled analysis of TRIBE and TRIBE2 studies by GONO 19
Anti-PD1 therapies induce an early expansion of Ki67+CD8+ T cells in metastatic non-oncogene addicted NSCLC patients 19
Evaluation of efficacy of ALK inhibitors according to body mass index in ALK rearranged NSCLC patients—A retrospective observational study 19
True conversions from RAS mutant to RAS wild-type in circulating tumor DNA from metastatic colorectal cancer patients as assessed by methylation and mutational signature 19
Comparative effects of Folfirinox and Gemcitabine/nab-paclitaxel as first and second line chemotherapy for metastatic pancreatic cancer: single choice or sequence 18
Why the therapeutic impact of RAS mutation clearance in plasma ctDNA deserves to be further explored in metastatic colorectal cancer 18
Parkinson's disease is associated with increased serum levels of macrophage migration inhibitory factor 17
In vitro and in vivo anticancer action of saquinavir-NO, a novel nitric oxide-derivative of the protease inhibitor saquinavir, on hormone resistant prostate cancer cells 17
TK inhibitor pazopanib primes DCs by downregulation of the β-catenin pathway 17
Baseline CD44v6-positive circulating tumor cells to predict first-line treatment failure in patients with metastatic colorectal cancer 17
P-158Radioembolization (SIRT) as a Consolidation Treatment in Colorectal Liver Metastases after First Line Chemotherapy: Efficacy Safety 17
MGL receptor and immunity: when the ligand can make the difference 16
Triple peptide vaccination as consolidation treatment in women affected by ovarian and breast cancer: clinical and immunological data of a phase I/II clinical trial 15
Prolactin as a potential early predictive factor in metastatic non-small cell lung cancer patients treated with Nivolumab 15
The macrophage Galactose-type C-type Lectin (MGL) modulates regulatory T cell functions 13
Intensified Total Neoadjuvant Therapy Versus Intensified Concurrent Chemoradiotherapy in Locally Advanced Rectal Cancer: A Propensity Score Matching Analysis 5
Totale 947
Categoria #
all - tutte 3.676
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.676


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/202544 0 0 0 0 0 0 1 1 4 20 5 13
2025/2026903 177 20 229 355 116 6 0 0 0 0 0 0
Totale 947